All Stories

  1. FGFR1 and KAT6A rearrangements in patients with hematological malignancies and chromosome 8p11 abnormalities: biological and clinical features

    Article • American Journal of Hematology, February 2016, Wiley

    Dr Carmen Baldazzi

  2. Complex chromosomal rearrangements leading toMECOMoverexpression are recurrent in myeloid malignancies with various 3q abnormalities

    Article • Genes Chromosomes and Cancer, January 2016, Wiley

    Dr Carmen Baldazzi

  3. Abstract B03: Very poor outcome and chemoresistance of acute myeloid leukemia patients with TP53 mutations: Correlation with complex karyotype and clinical outcome.

    Article • Clinical Cancer Research, August 2015, American Association for Cancer Research (AACR)

    Dr Carmen Baldazzi

  4. Abstract 4906: TP53 mutations are mutually exclusive with FLT3 and NPM mutations in AML patients and are strongly associated with complex karyotype and poor outcome

    Article • Cancer Research, August 2015, American Association for Cancer Research (AACR)

    Dr Carmen Baldazzi

  5. 4q12 translocations withGSX2expression identify a CD7+acute myeloid leukaemia subset

    Article • British Journal of Haematology, March 2015, Wiley

    Dr Carmen Baldazzi

  6. Abstract 570: Tp53 mutation screening in adult acute myeloid leukemia (AML) patients shows a strong association with complex karyotype and poor outcome

    Article • Cancer Research, September 2014, American Association for Cancer Research (AACR)

    Dr Carmen Baldazzi

  7. Abstract 746: PKC412 (Midostaurin) is safe and highly effective in systemic mastocytosis patients: Follow up of a single-center Italian compassionate use

    Article • Cancer Research, September 2014, American Association for Cancer Research (AACR)

    Dr Carmen Baldazzi

  8. Abstract CT312: Ponatinib is well tolerated and active in patients with relapsed/refractory philadelphia positive leukemias: The Bologna experience

    Article • Cancer Research, September 2014, American Association for Cancer Research (AACR)

    Dr Carmen Baldazzi

  9. Abstract 2082: PKC412 (Midostaurin) is safe and highly effective in Systemic Mastocytosis patients: the Bologna experience.

    Article • Cancer Research, April 2013, American Association for Cancer Research (AACR)

    Dr Carmen Baldazzi

  10. A novel t(2;10)(q31;p12) balanced translocation in acute myeloid leukemia

    Article • Hematology Reports, November 2012, PAGEPress Publications

    Dr Carmen Baldazzi

  11. Abstract 4619: PF-04449913 reverts multi drug resistance (MDR) by a strong down-regulation of ABCA2 and BCL2 on leukemia stem cells in phase I acute myeloid leukemia and chronic myeloid leukemia treated patients

    Article • Cancer Research, April 2012, American Association for Cancer Research (AACR)

    Dr Carmen Baldazzi

  12. Abstract 906: Gas1 and Kif27 genes are strongly up-regulated biomarkers of Hedgehog inhibition (PF-04449913) on leukemia stem cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia treated patients

    Article • Cancer Research, April 2012, American Association for Cancer Research (AACR)

    Dr Carmen Baldazzi

  13. Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis

    Article • Blood, March 2011, American Society of Hematology

    Dr Carmen Baldazzi

  14. B-cell acute lymphoblastic leukemia as evolution of a 8p11 myeloproliferative syndrome with t(8;22)(p11;q11) and BCR-FGFR1 fusion gene

    Article • Leukemia Research, October 2010, Elsevier

    Dr Carmen Baldazzi

  15. Chromosome abnormalities additional to the Philadelphia chromosome at the diagnosis of chronic myelogenous leukemia: pathogenetic and prognostic implications

    Article • Cancer Genetics and Cytogenetics, June 2010, Elsevier

    Dr Carmen Baldazzi, Dr ALESSANDRO Gozzetti

  16. Emergence of clonal chromosomal abnormalities in Philadelphia negative hematopoiesis in chronic myeloid leukemia patients treated with nilotinib after failure of imatinib therapy

    Article • Leukemia Research, December 2009, Elsevier

    Dr Carmen Baldazzi

  17. Influence of additional cytogenetic abnormalities on the response and survival in late chronic phase chronic myeloid leukemia patients treated with imatinib: long-term results

    Article • Leukemia & Lymphoma, January 2009, Taylor & Francis

    Dr Carmen Baldazzi

  18. Acute promyelocytic leukemia with amplification of PML-RARα rearrangement: Clinical implications

    Article • Leukemia Research, December 2008, Elsevier

    Dr Carmen Baldazzi